Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.
Oqvist
Björn
B
Brenner
Barry M
BM
Oliveira
João Paulo
JP
Ortiz
Alberto
A
Schaefer
Roland
R
Svarstad
Einar
E
Wanner
Christoph
C
Zhang
Kate
K
Warnock
David G
DG
D001706:Biopsy; D004252:DNA Mutational Analysis; D000795:Fabry Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007527:Isoenzymes / Q000627:therapeutic use; D007674:Kidney Diseases / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D015997:Neonatal Screening; D010375:Pedigree; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis; D012307:Risk Factors; D013997:Time Factors; D014281:Trihexosylceramides / Q000652:urine; D000519:alpha-Galactosidase / Q000097:blood / Q000235:genetics / Q000627:therapeutic use
D007527:Isoenzymes; D011994:Recombinant Proteins; D014281:Trihexosylceramides; C018549:globotriaosylceramide; D000519:alpha-Galactosidase